- NVAX +15.33%
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
Yahoo Finance · 1 week ago
Open | 13.60 |
High | 15.26 |
Low | 13.27 |
Mkt Cap | 2.23B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 13.11 |
52 Wk. Low | 3.53 |
52 Wk. High | 23.86 |
Related stocks
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus... Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 93.86M | 15.90% ▲ |
Net Income | -147.55M | - |
Diluted EPS | -1.05 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.36 | - |
Q1 2024 | -$1.06 | -$1.05 |
Q4 2023 | -$0.45 | -$1.44 |
S&P 500^GSPC | 5,631.22+15.87 (+0.28%) |
Dow 30^DJI | 40,211.72+210.82 (+0.53%) |
Nasdaq^IXIC | 18,472.57+74.17 (+0.40%) |
40.58+31.37% | |
Bitcoin USDBTC-USD | 64,811.01+6.27% |
242.85+11.39% |